UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect

Condition & Treatment Comparisons

Compare clinical trial landscapes across conditions and treatments in the UK

Explore how clinical trial availability, treatment approaches, and research opportunities differ between related conditions and treatment types. Each comparison provides UK-specific trial counts and practical guidance for patients.

Cancer Comparisons

Breast Cancer vs Ovarian Cancer

Breast cancer has more trial options due to higher incidence and established biomarker testing. Ovarian cancer trials fo...

Breast Cancer: ~104 recruitingOvarian Cancer: ~45 recruiting

Lung Cancer vs Mesothelioma

Lung cancer has far more trials driven by molecular subtyping. Mesothelioma has fewer but highly targeted trials, often ...

Lung Cancer (NSCLC): ~94 recruitingMesothelioma: ~20 recruiting

Prostate Cancer vs Colorectal Cancer

Prostate cancer trials often focus on treatment timing and sequencing. Colorectal cancer trials are more biomarker-drive...

Prostate Cancer: ~89 recruitingColorectal Cancer: ~75 recruiting

Melanoma vs Head & Neck Cancer

Melanoma is a flagship for immunotherapy trials. Head and neck cancer trials are more diverse, covering surgical, radiat...

Melanoma: ~28 recruitingHead & Neck Cancer: ~40 recruiting

Stomach Cancer vs Oesophageal Cancer

Both upper GI cancers share some treatment approaches but have different risk factors and surgical considerations. Oesop...

Stomach Cancer: ~20 recruitingOesophageal Cancer: ~30 recruiting

Bladder Cancer vs Kidney Cancer

Bladder cancer trials span BCG alternatives to radical surgery options. Kidney cancer trials are dominated by systemic t...

Bladder Cancer: ~25 recruitingKidney Cancer: ~30 recruiting

Brain Cancer vs Head & Neck Cancer

Brain cancer trials face unique challenges with the blood-brain barrier. Head and neck cancer trials are more diverse in...

Brain Cancer: ~30 recruitingHead & Neck Cancer: ~40 recruiting

Blood Cancer vs Melanoma

Blood cancer trials include cellular therapies (CAR-T) and transplant approaches. Melanoma trials pioneered checkpoint i...

Blood Cancer (Leukaemia): ~60 recruitingMelanoma: ~28 recruiting

Pancreatic Cancer vs Colorectal Cancer

Pancreatic cancer has fewer trials due to poor prognosis and difficulty in early detection. Colorectal cancer has more b...

Pancreatic Cancer: ~30 recruitingColorectal Cancer: ~75 recruiting

Small Cell vs Non-Small Cell Lung Cancer

SCLC has far fewer trials and treatment options. NSCLC has become a model for precision oncology with biomarker-guided t...

Small Cell Lung Cancer: ~15 recruitingNon-Small Cell Lung Cancer: ~94 recruiting

Breast Cancer vs Prostate Cancer

Both are hormone-driven cancers with established screening. Breast cancer has more molecular subtypes driving trial dive...

Breast Cancer: ~104 recruitingProstate Cancer: ~89 recruiting